Search Results - "Kwok, Carol Ch"

Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies by Yeo, Winnie, Li, Leung, Lau, Thomas Kh, Lai, Kwai T, Chan, Vicky Tc, Wong, Kwan H, Yip, Christopher Ch, Pang, Elizabeth, Cheung, Maggie, Chan, Vivian, Kwok, Carol Ch, Suen, Joyce Js, Mo, Frankie Kf

“…Chemotherapy-induced nausea and vomiting (CINV) are common with doxorubicin-cyclophosphamide (AC) chemotherapy. Recommended antiemetic regimens incorporate…”
Get full text

Preoperative considerations and benefits of neoadjuvant chemotherapy: insights from a 12-year review of the Hong Kong Breast Cancer Registry by Chan, Y H Y, Kwok, C C H, Tse, D M S, Lee, H M, Tam, P Y, Cheung, P S Y

“…Neoadjuvant chemotherapy (NAC) was initially used for locally advanced or inoperable breast cancers. Its extension to early disease has facilitated…”
Get full text

Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective cohort study by Kwok, C C H, Wong, W H, Chan, L L, Wong, S P Y, Wang, F, Wong, M C S, Tse, S L A

“…This study was performed to examine the effects of primary granulocyte-colony stimulating factor (G-CSF) prophylaxis on neutropenic toxicity, chemotherapy…”
Get full text

Evaluation of contemporary olanzapine- and netupitant/palonosetron-containing antiemetic regimens for chemotherapy-induced nausea and vomiting by Yip, C Ch, Li, L, Lau, T K H, Chan, V T C, Kwok, C C H, Suen, J J S, Mo, F K F, Yeo, W

“…This post-hoc analysis retrospectively assessed data from two recent studies of antiemetic regimens for chemotherapy-induced nausea and vomiting (CINV). The…”
Get full text

NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin by Yeo, Winnie, Lau, Thomas Kh, Kwok, Carol Ch, Lai, Kwai T, Chan, Vicky Tc, Li, Leung, Chan, Vivian, Wong, Ashley, Soo, Winnie Mt, Yeung, Eva Wm, Wong, Kam H, Tang, Nelson Ls, Suen, Joyce Js, Mo, Frankie Kf

“…This is a prospective study evaluating NEPA in patients with breast cancer (the NEPA group), who received (neo)adjuvant AC chemotherapy (consisting of…”
Get more information

Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective cohort study by Kwok, Carol CH, Wong, W H, Chan, Landon L, Sabrina PY Wong, Wang, F, Martin CS Wong, Shelly LA Tse

“…Introduction: This study was performed to examine the effects of primary granulocyte-colony stimulating factor (G-CSF) prophylaxis on neutropenic toxicity,…”
Get full text

The Impact of the Onco type DX® Breast Cancer Assay on Treatment Decisions for Women with Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong by Leung, Roland CY, Yau, Thomas CC, Chan, Miranda CM, Chan, Sharon WW, Chan, Terence WC, Tsang, Yvonne YY, Wong, Ting Ting, Chao, Calvin, Yoshizawa, Carl, Soong, Inda S, Kwan, Wing-Hong, Kwok, Carol CH, Suen, Joyce SJ, Ngan, Roger KC, Cheung, Polly SY

“…Abstract Background The Onco type DX® Breast Cancer Assay is validated to assess risk of distant recurrence and likelihood of chemotherapy (CT) benefit in ER+…”
Get full text